Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2015-04-15 | Mr. Brennan joined Insmed's Board of Directors in May 2014. From 2006 to 2012, Mr. Brennan was the Chief Executive Officer of AstraZeneca PLC, a global biopharmaceutical company. Previously at AstraZeneca, Mr. Brennan served as Executive Vice President of North America from 2001 to 2006; and as Senior Vice President of Commercialization and Portfolio Management from 1999 to 2001. Mr. Brennan also served as a member of the Board of Directors of AstraZeneca from 2005 to 2012. Prior to AstraZeneca, Mr. Brennan held various positions at Astra Pharmaceuticals, L.P., Astra Merck, Inc. and Merck and Co. Inc. Mr. Brennan also serves as a member of the board of directors of Alexion Pharmaceuticals and a member of the Supervisory Board of Innocoll AG. Mr. Brennan received a B.A. in Business Administration from Gettysburg College. |
| 2017-04-07 | Mr. Brennan has more than 37 years of experience in the pharmaceutical industry. The Board believes that Mr. Brennan's public company and public company board experience at pharmaceutical companies, including roles in executive management, commercialization and product management makes him a valuable asset to the Board. |
| 2018-04-05 | Mr. Brennan's public company and public company board experience at pharmaceutical companies, including roles in executive management, commercialization and product management. |
| 2019-04-04 | Education: Gettysburg College - B.A., business administration |
| 2020-03-31 | Education: Gettysburg College - B.A., business administration |
| 2021-04-01 | Mr. Brennan’s experience at public pharmaceutical companies, including board experience and roles in executive management, commercialization and product management. |
| 2022-04-01 | Education: Gettysburg College - B.A., business administration |
| 2023-03-31 | Education: Gettysburg College – B.A., business administration |
| 2024-04-01 | Mr. Brennan has more than 45 years of experience in the pharmaceutical industry. The Board believes that Mr. Brennan’s experience at public pharmaceutical companies, including board experience and roles in executive management, commercialization, and product management, makes him a valuable asset to the Board. |
| 2025-04-04 | Education: Gettysburg College – B.A., business administration |
Data sourced from SEC filings. Last updated: 2026-02-03